Cancer-Associated Fibroblasts in Gastrointestinal Cancer Metastasis: Mechanisms and Emerging Therapeutic Strategies
Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-29
DOI: 10.2147/dddt.s620950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Shasha Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department of Integrated Chinese and Western Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of C…. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Cancer-Associated Fibroblasts, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Metastasis is the primary cause of mortality across gastrointestinal (GI) cancers, including colorectal, gastric, pancreatic, biliary and esophageal cancers. Cancer-associated fibroblasts (CAFs) constitute the dominant stromal component of the desmoplastic GI tumor microenvironment (TME) and regulate every stage of metastatic progression. This review systematically summarizes CAF-mediated pro-metastatic mechanisms in GI tumors, including extracellular matrix (ECM) remodeling, paracrine oncogenic signaling, immune exclusion, angiogenesis, lymphangiogenesis, pre-metastatic niches (PMNs) construction and therapeutic resistance. Notably, CAFs are heterogeneous populations with context-dependent dual functions: certain myofibroblastic CAF (myCAF) subsets restrain tumor progression in pancreatic ductal adenocarcinoma (PDAC), while inflammatory CAFs (iCAFs) drive metastasis and immune suppression. Antigen-presenting CAFs (apCAFs) exert divergent immunomodulatory effects depending on tumor context. Rather than acting as uniformly tumor-promoting stromal cells, CAFs represent heterogeneous and plastic populations whose functions vary by tumor type, spatial niche, and metastatic stage. We further discuss why broad CAF depletion has shown limited clinical success and emphasize the need for subtype-specific, context- aware CAF-targeted strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Department of Integrated Chinese and Western Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
- Key Laboratory for TCM Diagnosis and Treatment of Digestive Tract Tumors in Hebei Province, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Zitieren
APA
Gao, S., Song, Y., Qiao, Y., Gao, Z., Ma, J., Huo, B., Li, S., & Cao, M. (2026). Cancer-Associated Fibroblasts in Gastrointestinal Cancer Metastasis: Mechanisms and Emerging Therapeutic Strategies. Drug Design, Development and Therapy, Volume 20, 1-29. https://doi.org/10.2147/dddt.s620950
Vancouver
Gao S, Song Y, Qiao Y, Gao Z, Ma J, Huo B, et al. Cancer-Associated Fibroblasts in Gastrointestinal Cancer Metastasis: Mechanisms and Emerging Therapeutic Strategies. Drug Design, Development and Therapy. 2026;Volume 20:1-29. doi:10.2147/dddt.s620950
BibTeX
@article{Gao2026,
author = {Gao, Shasha and Song, Yanru and Qiao, Yining and Gao, Zihan and Ma, Jiao and Huo, Bingjie and Li, Shenghao and Cao, Miao},
title = {Cancer-Associated Fibroblasts in Gastrointestinal Cancer Metastasis: Mechanisms and Emerging Therapeutic Strategies},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--29},
doi = {10.2147/dddt.s620950}
}
EUVIMED